Vitronectin: growth factor complexes hold potential as a wound therapy approach

Simple item page
dc.contributor.authorUpton, Z.
dc.contributor.authorCuttle, L.
dc.contributor.authorNoble, A.
dc.contributor.authorKempf, M.
dc.contributor.authorTopping, G.
dc.contributor.authorMalda, J.
dc.contributor.authorXie, Y.
dc.contributor.authorMill, J.
dc.contributor.authorHarkin, D.
dc.contributor.authorKravchuk, O.
dc.contributor.authorLeavesley, D.
dc.contributor.authorKimble, R.
dc.date.issued2008
dc.description.abstractTopical administration of growth factors has displayed some potential in wound healing, but variable efficacy, high doses, and costs have hampered their implementation. Moreover, this approach ignores the fact that wound repair is driven by interactions between multiple growth factors and extracellular matrix (ECM) proteins. We report herein that complexes comprising IGF and IGF-binding proteins bound to the ECM protein vitronectin (VN) significantly enhance cellular functions relevant to wound repair in human skin keratinocytes in two- and three-dimensional in vitro cell models and are active, even in the presence of wound fluid. Moreover, these responses require activation of both the IGF receptor and the VN-binding av integrins. Further, we assessed the complexes as a topical agent in the treatment of deep dermal partial thickness burns in a porcine model. This pilot study revealed that the complexes may hold promise as a wound healing therapy. Critically, the significant responses observed in vitro and the encouraging preliminary data in vivo were obtained with nanogram doses of growth factors. This suggests that coupling delivery of growth factors to ECM proteins such as VN may ultimately prove to be a more effective strategy for developing a wound healing therapy.
dc.description.statementofresponsibilityZee Upton, Leila Cuttle, Anthony Noble, Margit Kempf, Gemma Topping, Jos Malda, Yan Xie, Julie Mill, Damien G Harkin, Olena Kravchuk, David I Leavesley and Roy M Kimble
dc.identifier.citationJournal of Investigative Dermatology, 2008; 128(6):1535-1544
dc.identifier.doi10.1038/sj.jid.5701148
dc.identifier.issn0022-202X
dc.identifier.issn1523-1747
dc.identifier.orcidKravchuk, O. [0000-0001-5291-3600]
dc.identifier.urihttp://hdl.handle.net/2440/69177
dc.language.isoen
dc.publisherBlackwell Publishing Inc
dc.rightsCopyright 2008 The Society for Investigative Dermatology
dc.source.urihttps://doi.org/10.1038/sj.jid.5701148
dc.subjectExtracellular Matrix
dc.subjectKeratinocytes
dc.subjectSkin
dc.subjectAnimals
dc.subjectSwine
dc.subjectHumans
dc.subjectIntercellular Signaling Peptides and Proteins
dc.subjectVitronectin
dc.subjectInsulin-Like Growth Factor Binding Protein 3
dc.subjectInsulin-Like Growth Factor Binding Protein 5
dc.subjectIntegrin alphaV
dc.subjectWound Healing
dc.subjectCell Movement
dc.subjectGene Expression Regulation
dc.titleVitronectin: growth factor complexes hold potential as a wound therapy approach
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Agriculture, Food and Wine publications